Connect with us

Business

Federal Authorities Begins Nationwide Diabetes Screening and Coaching Programme Utilizing Regionally Manufactured OnPoint Glucose Monitoring Techniques. …Colexa Biosensor Commends Initiative as Rollout Begins in North-Central Nigeria Lagos, Nigeria — November 17, 2025 — Colexa Biosensor Ltd, Nigeria’s pioneer producer of blood glucose monitoring programs, proclaims the graduation of the Federal Authorities’s nationwide diabetes screening and capacity-building programme, following the procurement of important medical provides, together with domestically manufactured diabetes diagnostic kits. The initiative formally kicked off this week within the North-Central geopolitical zone, starting with the coaching of presidency well being officers throughout major healthcare centres (PHCs). This will probably be adopted by a nationwide screening marketing campaign concentrating on 5 million Nigerians throughout the 774 Native Authorities Areas of the nation. As a part of this effort, the Federal Authorities will distribute greater than 77,000 models of the OnPoint Blood Glucose Monitoring System, produced by Colexa Biosensor in Lagos, to people recognized with diabetes throughout the nationwide screening train. Every PHC can even obtain diagnostic and monitoring gadgets to assist ongoing community-level diabetes care. This programme marks a serious milestone in advancing native manufacturing, bettering entry to early prognosis, and strengthening Nigeria’s healthcare worth chain. Talking on the event, the Nationwide Desk officer, Diabetes of the Federal Ministry of Well being, Dr. Alayo Sopekan, described diabetes as one of many fastest-growing well being burdens in Nigeria, emphasizing the pressing want for early detection and monitoring: “We’ve many Nigerians residing with diabetes, some are conscious, many usually are not. This initiative is geared toward figuring out early, these residing with diabetes, bettering entry, decreasing price, and strengthening our native capability according to the administration’s dedication to unlocking the healthcare worth chain.” Colexa Biosensor expressed appreciation at being chosen as a key native producer for this nationwide programme and reiterated its dedication to supporting Nigeria’s combat in opposition to non-communicable ailments. In keeping with Pharm. Kingsley Aguoru, Managing Director of Colexa Biosensor: “This partnership displays the Federal Authorities’s confidence in Nigerian manufacturing capability. At Colexa Biosensor, we stay dedicated to delivering high-quality, dependable diagnostic instruments to enhance early detection and long-term administration of diabetes throughout the nation.” The programme additionally aligns with the Federal Authorities’s broader medical aid agenda geared toward decreasing the price of important well being commodities, bettering affordability, and strengthening diagnostic companies nationwide. Coaching and screening actions will proceed throughout all six geo-political zones within the coming weeks. For media enquiries, please contact: Company Communications Unit Colexa Biosensor Ltd [email protected]

Published

on

 

…Colexa Biosensor Commends Initiative as Rollout Begins in North-Central Nigeria

Colexa Biosensor Ltd, Nigeria’s pioneer producer of blood glucose monitoring programs, proclaims the graduation of the Federal Authorities’s nationwide diabetes screening and capacity-building programme, following the procurement of important medical provides, together with domestically manufactured diabetes diagnostic kits.

 

The initiative formally kicked off this week within the North-Central geopolitical zone, starting with the coaching of presidency well being officers throughout major healthcare centres (PHCs). This will probably be adopted by a nationwide screening marketing campaign concentrating on 5 million Nigerians throughout the 774 Native Authorities Areas of the nation.

 

As a part of this effort, the Federal Authorities will distribute greater than 77,000 models of the OnPoint Blood Glucose Monitoring System, produced by Colexa Biosensor in Lagos, to people recognized with diabetes throughout the nationwide screening train. Every PHC can even obtain diagnostic and monitoring gadgets to assist ongoing community-level diabetes care.

 

This programme marks a serious milestone in advancing native manufacturing, bettering entry to early prognosis, and strengthening Nigeria’s healthcare worth chain.

 

Talking on the event, the Nationwide Desk officer, Diabetes of the Federal Ministry of Well being, Dr. Alayo Sopekan, described diabetes as one of many fastest-growing well being burdens in Nigeria, emphasizing the pressing want for early detection and monitoring:

“We’ve many Nigerians residing with diabetes, some are conscious, many usually are not. This initiative is geared toward figuring out early, these residing with diabetes, bettering entry, decreasing price, and strengthening our native capability according to the administration’s dedication to unlocking the healthcare worth chain.”

 

Colexa Biosensor expressed appreciation at being chosen as a key native producer for this nationwide programme and reiterated its dedication to supporting Nigeria’s combat in opposition to non-communicable ailments.

 

In keeping with Pharm. Kingsley Aguoru, Managing Director of Colexa Biosensor:

“This partnership displays the Federal Authorities’s confidence in Nigerian manufacturing capability. At Colexa Biosensor, we stay dedicated to delivering high-quality, dependable diagnostic instruments to enhance early detection and long-term administration of diabetes throughout the nation.”

 

The programme additionally aligns with the Federal Authorities’s broader medical aid agenda geared toward decreasing the price of important well being commodities, bettering affordability, and strengthening diagnostic companies nationwide.

Coaching and screening actions will proceed throughout all six geo-political zones within the coming weeks.

 

For media enquiries, please contact:

Company Communications Unit

Colexa Biosensor Ltd

[email protected]

Trending